![Petter Sivlér](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Petter Sivlér is the founder and Chief Executive Officer of S2Medical AB, which was founded in 2013.
He is currently the Chief Executive Officer & Director of Instagraft AB, Chairman of hénsus AB, Director of SivlerSkog Group AB, Director of Atio AB, and Director of SivlérSkog Empire AB.
| Società | Posizione | Inizio |
|---|---|---|
| S2MEDICAL AB | Amministratore Delegato | 13/06/2013 |
Instagraft AB
 Instagraft AB Miscellaneous Commercial ServicesCommercial Services Engages in the research and experimental development on biotechnology | Amministratore Delegato | - |
SivlerSkog Group AB | Direttore/Membro del Consiglio | - |
Atio AB | Direttore/Membro del Consiglio | - |
hénsus AB | Presidente | - |
SivlérSkog Empire AB | Direttore/Membro del Consiglio | - |
Attive
Inattive
Società nel listino
Aziende private
| Aziende private | 6 |
|---|---|
S2Medical AB
 S2Medical AB BiotechnologyHealth Technology Engages in research and development in biotechnology | Health Technology |
SivlerSkog Group AB | |
Instagraft AB
Instagraft AB Miscellaneous Commercial ServicesCommercial Services Engages in the research and experimental development on biotechnology | Commercial Services |
Atio AB | |
SivlérSkog Empire AB | |
hénsus AB |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
